Verve Therapeutics logo

Verve Therapeutics Share Price Today

(NASDAQ: VERV)

Verve Therapeutics share price is $6.55 & ₹569.65 as on 6 Mar 2025, 2.30 'hrs' IST

$6.55

0.43

(7.03%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Verve Therapeutics share price in Dollar and Rupees. Guide to invest in Verve Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Verve Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Verve Therapeutics share price movements

  • Today's Low: $5.91
    Today's High: $6.56

    Day's Volatility :9.91%

  • 52 Weeks Low: $4.31
    52 Weeks High: $16.05

    52 Weeks Volatility :73.18%

Verve Therapeutics (VERV) Returns

PeriodVerve Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
0.16%
2.1%
0.0%
6 Months
10.67%
-4.1%
0.0%
1 Year
-59.39%
2.2%
0.0%
3 Years
-77.32%
11.8%
-11.6%

Verve Therapeutics (VERV) Key Statistics

in dollars & INR

Previous Close
$6.12
Open
$6.18
Today's High
$6.56
Today's Low
$5.91
Market Capitalization
$547.9M
Today's Volume
$408.4K
52 Week High
$16.05
52 Week Low
$4.305
Revenue TTM
$32.3M
EBITDA
$-221.9M
Earnings Per Share (EPS)
$-2.35
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-36.36%

How to invest in Verve Therapeutics Stock (VERV) from India?

It is very easy for Indian residents to invest directly in Verve Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Verve Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Verve Therapeutics or VERV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Verve Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Verve Therapeutics shares which would translate to 0.133 fractional shares of Verve Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Verve Therapeutics, in just a few clicks!

Returns in Verve Therapeutics (VERV) for Indian investors in Rupees

The Verve Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Verve Therapeutics investment value today

Current value as on today

₹48,427

Returns

₹51,573

(-51.57%)

Returns from Verve Therapeutics Stock

₹56,536 (-56.54%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Verve Therapeutics (VERV)

160%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Verve Therapeutics Stock from India on INDmoney has increased by 160% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Verve Therapeutics

  • Alphabet Inc

    13.91%

  • BlackRock Inc

    8.48%

  • Bvf Inc

    7.78%

  • Vanguard Group Inc

    4.51%

  • Casdin Capital, LLC

    4.50%

  • Millennium Management LLC

    4.41%

Analyst Recommendation on Verve Therapeutics

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Verve Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
13
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Verve Therapeutics Stock (VERV)

What analysts predicted

Upside of 259.39%

Target:

$23.54

Current:

$6.55

Insights on Verve Therapeutics Stock (Ticker Symbol: VERV)

  • Price Movement

    In the last 1 month, VERV stock has moved down by -29.1%
  • Increasing Revenue

    Revenue is up for the last 10 quarters, 929.0K → 13.08M (in $), with an average increase of 24.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -50.13M → -50.03M (in $), with an average increase of 0.2% per quarter
  • VERV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 121.9%
  • VERV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.6%
  • Price to Sales

    ForVERV every $1 of sales, investors are willing to pay $16.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Verve Therapeutics Technicals Summary

Sell

Neutral

Buy

Verve Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Verve Therapeutics (VERV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Verve Therapeutics Inc logo
-18.62%
10.67%
-59.39%
-77.32%
-86.7%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Verve Therapeutics Inc logo
2.34
NA
NA
-2.67
-0.36
-0.2
NA
5.56
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Verve Therapeutics Inc logo
Buy
$547.9M
-86.7%
2.34
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Verve Therapeutics

Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for the treatment of HeFH. It engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Organization
Verve Therapeutics
Employees
274
CEO
Dr. Sekar Kathiresan M.D.
Industry
Services

Management People of Verve Therapeutics

NameTitle
Dr. Burt A. Adelman M.D.
Co-Founder & Independent Chairman of the Board
Dr. Sekar Kathiresan M.D.
Co-Founder, CEO & Director
Mr. Andrew D. Ashe J.D.
President, COO & General Counsel
Dr. Kiran Musunuru M.D., M.P.H., Ph.D.
Co-Founder
Dr. J. Keith Joung M.D., Ph.D.
Co-Founder
Dr. Anthony Philippakis M.D., Ph.D.
Co-Founder & Scientific Advisory Board Member
Dr. Barry S. Ticho FACC, M.D., Ph.D.
Co-Founder
Mr. Issi Rozen M.B.A.
Co-Founder & Strategic Advisor
Dr. Troy Lister Ph.D.
Chief Scientific Officer
Ms. Joan Nickerson M.B.A.
Chief Administrative Officer

Important FAQs about investing in VERV Stock from India :

What is Verve Therapeutics share price today?

Verve Therapeutics share price today stands at $6.55, Open: $6.18 ; Previous Close: $6.12 ; High: $6.56 ; Low: $5.91 ; 52 Week High: $16.05 ; 52 Week Low: $4.31.

The stock opens at $6.18, after a previous close of $6.12. The stock reached a daily high of $6.56 and a low of $5.91, with a 52-week high of $16.05 and a 52-week low of $4.31.

Can Indians buy Verve Therapeutics shares?

Yes, Indians can invest in the Verve Therapeutics (VERV) from India.

With INDmoney, you can buy Verve Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Verve Therapeutics at zero transaction cost.

How can I buy Verve Therapeutics shares from India?

It is very easy to buy Verve Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Verve Therapeutics (VERV) be purchased?

Yes, you can buy fractional shares of Verve Therapeutics with INDmoney app.

What are the documents required to start investing in Verve Therapeutics stocks?

To start investing in Verve Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Verve Therapeutics Stock (VERV)?

Today’s highest price of Verve Therapeutics (VERV) is $6.56.

Today’s lowest price of Verve Therapeutics (VERV) is $5.91.

What is today's market capitalisation of Verve Therapeutics?

Today's market capitalisation of Verve Therapeutics VERV is 547.9M

What is the 52 Week High and Low Range of Verve Therapeutics Stock (VERV)?

  • 52 Week High

    $16.05

  • 52 Week Low

    $4.31

What are the historical returns of Verve Therapeutics (VERV)?

  • 1 Month Returns

    -18.62%

  • 3 Months Returns

    10.67%

  • 1 Year Returns

    -59.39%

  • 5 Years Returns

    -86.7%

Who is the Chief Executive Officer (CEO) of Verve Therapeutics ?

Dr. Sekar Kathiresan M.D. is the current Chief Executive Officer (CEO) of Verve Therapeutics.